{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T22:16:00Z","timestamp":1782166560295,"version":"3.54.5"},"reference-count":22,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,10,16]],"date-time":"2014-10-16T00:00:00Z","timestamp":1413417600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"funder":[{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.rmed.2014.10.002","type":"journal-article","created":{"date-parts":[[2014,10,15]],"date-time":"2014-10-15T16:53:18Z","timestamp":1413391998000},"page":"1752-1760","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":90,"title":["Efficacy and safety of umeclidinium\/vilanterol 62.5\/25\u00a0mcg and tiotropium 18\u00a0mcg in chronic obstructive pulmonary disease: Results of a 24-week, randomized, controlled trial"],"prefix":"10.1016","volume":"108","author":[{"given":"M. Reza","family":"Maleki-Yazdi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Kaelin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Richard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Zvarich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Church","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rmed.2014.10.002_bib1","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1183\/09031936.04.00014304","article-title":"ATS\/ERS Task Force, standards for the diagnosis and treatment of patients with COPD: a summary of the ATS\/ERS position paper","volume":"23","author":"Celli","year":"2004","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmed.2014.10.002_bib2","unstructured":"GOLD, Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease, http:\/\/www.goldcopd.org\/ [accessed March 2014]."},{"key":"10.1016\/j.rmed.2014.10.002_bib3","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1183\/09059180.00009902","article-title":"Reducing cholinergic constriction: the major reversible mechanism in COPD","volume":"15","author":"Brusasco","year":"2006","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.rmed.2014.10.002_bib4","unstructured":"Global Initiative for Chronic Obstructive Lung Disease, Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease, revised 2011, http:\/\/www.goldcopd.org\/uploads\/users\/files\/GOLD_Report_2011_Feb21.pdf [accessed March 2014]."},{"key":"10.1016\/j.rmed.2014.10.002_bib5","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1136\/thoraxjnl-2011-201140","article-title":"Concurrent use of indacaterol plus tiotropium in patients with COPD provides superior bronchodilation compared with tiotropium alone: a randomised, double-blind comparison","volume":"67","author":"Mahler","year":"2012","journal-title":"Thorax"},{"key":"10.1016\/j.rmed.2014.10.002_bib6","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.pupt.2010.07.003","article-title":"Combined treatment with formoterol and tiotropium is more efficacious than treatment with tiotropium alone in patients with chronic obstructive pulmonary disease, regardless of smoking status, inhaled corticosteroid use, baseline severity, or gender","volume":"24","author":"Tashkin","year":"2011","journal-title":"Pulm Pharmacol Ther"},{"issue":"Suppl. 5","key":"10.1016\/j.rmed.2014.10.002_bib7","first-page":"1014s","article-title":"Four weeks oncedaily treatment with tiotropium+olodaterol (BI1744) fixed dose combination compared with tiotropium in COPD patients (5557)","volume":"38","author":"Maltais","year":"2010","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmed.2014.10.002_bib8","doi-asserted-by":"crossref","DOI":"10.1378\/chest.13-1579","article-title":"Once-daily umeclidinium\/vilanterol 125\/25\u00a0mcg in COPD: a randomized, controlled study","author":"Celli","year":"2014","journal-title":"Chest"},{"key":"10.1016\/j.rmed.2014.10.002_bib9","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.resp.2012.08.022","article-title":"Bronchodilation of umeclidinium, a new long-acting muscarinic antagonist, in COPD patients","volume":"185","author":"Decramer","year":"2013","journal-title":"Respir Physiol Neurobiol"},{"key":"10.1016\/j.rmed.2014.10.002_bib10","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1016\/j.rmed.2013.06.001","article-title":"Efficacy and safety of once-daily umeclidinium\/vilanterol 62.5\/25\u00a0mcg in COPD","volume":"107","author":"Donohue","year":"2013","journal-title":"Respir Med"},{"key":"10.1016\/j.rmed.2014.10.002_bib11","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1183\/09031936.00033213","article-title":"Umeclidinium in patients with COPD: a randomised, placebo-controlled study","volume":"43","author":"Trivedi","year":"2014","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmed.2014.10.002_bib12","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/S2213-2600(14)70065-7","article-title":"Efficacy and safety of umeclidinium plus vilanterol versus tiotropium, vilanterol, or umeclidinium monotherapies over 24 weeks in patients with chronic obstructive pulmonary disease: results from two multicentre, blinded, randomised controlled trials","volume":"2","author":"Decramer","year":"2014","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.rmed.2014.10.002_bib13","unstructured":"Boehringer-Ingelheim, Tiotropium prescribing information, http:\/\/bidocs.boehringer-ingelheim.com\/BIWebAccess\/ViewServlet.ser?docBase=renetnt&folderPath=\/Prescribing+Information\/PIs\/Spiriva\/Spiriva.pdf [accessed March 2014]."},{"key":"10.1016\/j.rmed.2014.10.002_bib14","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1080\/10543400802609797","article-title":"MMRM vs. LOCF: a comprehensive comparison based on simulation study and 25 NDA datasets","volume":"19","author":"Siddiqui","year":"2009","journal-title":"J Biopharm Stat"},{"key":"10.1016\/j.rmed.2014.10.002_bib15","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1080\/15412550902724073","article-title":"Formoterol and tiotropium compared with tiotropium alone for treatment of COPD","volume":"6","author":"Tashkin","year":"2009","journal-title":"COPD"},{"key":"10.1016\/j.rmed.2014.10.002_bib16","first-page":"A3762","article-title":"Bronchodilator response to the long-acting bronchodilator combination of umeclidinium\/vilanterol across subgroups of patients with COPD","volume":"vol. 189","author":"Han","year":"2014"},{"key":"10.1016\/j.rmed.2014.10.002_bib17","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1183\/09031936.00200212","article-title":"Dual bronchodilation with QVA149 versus single bronchodilator therapy: the SHINE study","volume":"42","author":"Bateman","year":"2013","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmed.2014.10.002_bib18","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1517\/14656566.2013.776539","article-title":"Aclidinium bromide\/formoterol fumarate fixed-dose combination for the treatment of chronic obstructive pulmonary disease","volume":"14","author":"Cazzola","year":"2013","journal-title":"Expert. Opin Pharmacother"},{"key":"10.1016\/j.rmed.2014.10.002_bib19","doi-asserted-by":"crossref","first-page":"405","DOI":"10.2165\/00002512-200421060-00005","article-title":"Cardiovascular safety of beta(2)-adrenoceptor agonist use in patients with obstructive airway disease: a systematic review","volume":"21","author":"Salpeter","year":"2004","journal-title":"Drugs Aging"},{"key":"10.1016\/j.rmed.2014.10.002_bib20","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1001\/jama.300.12.1439","article-title":"Inhaled anticholinergics and risk of major adverse cardiovascular events in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis","volume":"300","author":"Singh","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.rmed.2014.10.002_bib21","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1378\/chest.128.4.2005","article-title":"Comorbidity and mortality in copd-related hospitalizations in the united states, 1979 to 2001","volume":"128","author":"Holguin","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.rmed.2014.10.002_bib22","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1378\/chest.128.4.2099","article-title":"Patterns of comorbidities in newly diagnosed COPD and asthma in primary care","volume":"128","author":"Soriano","year":"2005","journal-title":"Chest"}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611114003345?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611114003345?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T11:31:32Z","timestamp":1760614292000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611114003345"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":22,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["S0954611114003345"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2014.10.002","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of umeclidinium\/vilanterol 62.5\/25\u00a0mcg and tiotropium 18\u00a0mcg in chronic obstructive pulmonary disease: Results of a 24-week, randomized, controlled trial","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2014.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}